Tirzepatide trials for Overweight or Obesity

All Tirzepatide trials · All Overweight or Obesity trials

Phase breakdown

Recruiting trials studying Tirzepatide for Overweight or Obesity

• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
  NCT06864026 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 55 locations
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 39 locations
• The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
  NCT06606821 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many trials study Tirzepatide for Overweight or Obesity?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.